Antituberculosis Drugs | List of Frontiers open access articles

Systematic Review

Published on 05 Dec 2025

Non-tuberculous mycobacterial infections in mainland China and Taiwan: a systematic review and meta-analysis of epidemiology, species distribution, and drug resistance (2013–2024)

in Infectious Diseases: Epidemiology and Prevention

Xinru Xu
Yanyi Lei
Li Zheng

Frontiers in Public Health

doi 10.3389/fpubh.2025.1676715

1,954 views
1 citation

Case Report

Published on 24 Feb 2022

Case Report: DRESS Syndrome Induced by Two Antituberculosis Drugs in an 8-Year-Old Girl

in Pediatric Gastroenterology, Hepatology and Nutrition

Vaidotas Urbonas
Dominykas Varnas
Kristina Mociskiene
Violeta Kvedariene
Odilija Rudzeviciene

Frontiers in Pediatrics

doi 10.3389/fped.2022.830611

6,650 views
7 citations

Case Report

Published on 11 Oct 2022

Chronic oral mucocutaneous candidiasis, recurrent respiratory infection, hepatosplenomegaly, and autoimmune diabetes mellitus: A case report of a gain-of-function mutation of STAT1 in a Chinese boy

in Pediatric Endocrinology

Bingyan Cao
Meijuan Liu
Yun Zhao
Chunxiu Gong

Frontiers in Pediatrics

doi 10.3389/fped.2022.1001290

3,290 views
6 citations

Original Research

Published on 23 Nov 2018

MtrA Response Regulator Controls Cell Division and Cell Wall Metabolism and Affects Susceptibility of Mycobacteria to the First Line Antituberculosis Drugs

in Microbial Physiology and Metabolism

Purushotham Gorla
Renata Plocinska
Krishna Sarva
Akash T. Satsangi
Emmanuel Pandeeti
Robert Donnelly
Jaroslaw Dziadek
Malini Rajagopalan
Murty V. Madiraju

Frontiers in Microbiology

doi 10.3389/fmicb.2018.02839

11,096 views
54 citations

Original Research

Published on 25 Jun 2019

The Anti-mycobacterial Activity of a Diterpenoid-Like Molecule Operates Through Nitrogen and Amino Acid Starvation

in Antimicrobials, Resistance and Chemotherapy

Alessandra Crusco
Rafael Baptista
Sumana Bhowmick
Manfred Beckmann
Luis A. J. Mur
Andrew D. Westwell
Karl F. Hoffmann

Frontiers in Microbiology

doi 10.3389/fmicb.2019.01444

8,902 views
3 citations

Original Research

Published on 28 Apr 2015

Enhancement of antibiotic activity by efflux inhibitors against multidrug resistant Mycobacterium tuberculosis clinical isolates from Brazil

in Antimicrobials, Resistance and Chemotherapy

Tatiane Coelho
Diana Machado
Isabel Couto
Raquel Maschmann
Daniela Ramos
Andrea von Groll
Maria L. Rossetti
Pedro A. Silva
Miguel Viveiros

Frontiers in Microbiology

doi 10.3389/fmicb.2015.00330

11,237 views
74 citations

Original Research

Published on 23 Jul 2024

Clinical risk factors for moderate and severe antituberculosis drug-induced liver injury

in Pharmacology of Infectious Diseases

Quanxian Liu
Lu Huang
Hong Yan
Zhaojing Zong
Zhenyong Chen
Xiaoyan Wu
Ling Chen
Yuanbo Lan

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1406454

4,527 views
11 citations

Brief Research Report

Published on 08 Oct 2021

Pharmacokinetics and Drug-Drug Interactions of Abacavir and Lamuvudine Co-administered With Antituberculosis Drugs in HIV-Positive Children Treated for Multidrug-Resistant Tuberculosis

in Drugs Outcomes Research and Policies

Louvina E. van der Laan
Anthony J. Garcia-Prats
H. Simon Schaaf
Jana L. Winckler
Heather Draper
Jennifer Norman
Lubbe Wiesner
Helen McIlleron
Paolo Denti
Anneke C. Hesseling

Frontiers in Pharmacology

doi 10.3389/fphar.2021.722204

5,610 views
7 citations

Original Research

Published on 02 Sep 2024

A cheminformatics and network pharmacology approach to elucidate the mechanism of action of Mycobacterium tuberculosis γ-carbonic anhydrase inhibitors

in Pharmacology of Infectious Diseases

Ajay Manaithiya
Ratul Bhowmik
Kunal Bhattacharya
Rajarshi Ray
Sagar Singh Shyamal
Fabrizio Carta
Claudiu T. Supuran
Seppo Parkkila
Ashok Aspatwar

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1457012

4,356 views
7 citations

Original Research

Published on 22 Aug 2016

HLA-DQ B10201 and A10102 Alleles Are Not Responsible for Antituberculosis Drug-Induced Hepatotoxicity Risk in Spanish Population

in Pulmonary Medicine

Virginia Leiro-Fernández
Diana Valverde
Rafael Vázquez-Gallardo
Lucía Constenla-Caramés
Víctor del Campo-Pérez
Alberto Fernández-Villar

Frontiers in Medicine

doi 10.3389/fmed.2016.00034

4,323 views
6 citations

Articles

Non-tuberculous mycobacterial infections in mainland China and Taiwan: a systematic review and meta-analysis of epidemiology, species distribution, and drug resistance (2013–2024)

Case Report: DRESS Syndrome Induced by Two Antituberculosis Drugs in an 8-Year-Old Girl

Chronic oral mucocutaneous candidiasis, recurrent respiratory infection, hepatosplenomegaly, and autoimmune diabetes mellitus: A case report of a gain-of-function mutation of STAT1 in a Chinese boy

MtrA Response Regulator Controls Cell Division and Cell Wall Metabolism and Affects Susceptibility of Mycobacteria to the First Line Antituberculosis Drugs

The Anti-mycobacterial Activity of a Diterpenoid-Like Molecule Operates Through Nitrogen and Amino Acid Starvation

Enhancement of antibiotic activity by efflux inhibitors against multidrug resistant Mycobacterium tuberculosis clinical isolates from Brazil

Clinical risk factors for moderate and severe antituberculosis drug-induced liver injury

Pharmacokinetics and Drug-Drug Interactions of Abacavir and Lamuvudine Co-administered With Antituberculosis Drugs in HIV-Positive Children Treated for Multidrug-Resistant Tuberculosis

A cheminformatics and network pharmacology approach to elucidate the mechanism of action of Mycobacterium tuberculosis γ-carbonic anhydrase inhibitors

HLA-DQ B1*0201 and A1*0102 Alleles Are Not Responsible for Antituberculosis Drug-Induced Hepatotoxicity Risk in Spanish Population

HLA-DQ B10201 and A10102 Alleles Are Not Responsible for Antituberculosis Drug-Induced Hepatotoxicity Risk in Spanish Population